Inactief instrument

Koers Baxalta Inc

Aandelen

slotkoers Nyse Andere beurzen
- ^USD	-

Baxalta : Shire Completes Combination With Baxalta Creating the Global Leader in Rare Diseases and Highly Specialized Conditions	03-06-16
Baxalta : CORRECTING and REPLACING Baxalta Shareholders Vote to Approve Combination	27-05-16
Baxalta : OncoResponse Secures Investment from Baxalta	26-05-16
Baxalta : Reports Positive Phase 1 Results for BAX 930, Investigational Recombinant ADAMTS13 to Treat Hereditary Thrombotic Thrombocytopenic Purpura (hTTP)	25-05-16
Baxalta : Thunderbolt Pharma, Inc., a Vitesse Biologics Company, Acquires Rights to BAFF/APRIL Dual Antagonist Program from Astellas Pharma Inc.	25-05-16

Sector

	Vaira. 1 jan.	Kapi.
CSL LIMITED	-4,66%	86,13 mld.
SAMSUNG BIOLOGICS CO.,LTD.	+1,32%	39,82 mld.
BIOGEN INC.	-19,27%	30,42 mld.
UCB	+57,86%	25,23 mld.
BIOMARIN PHARMACEUTICAL INC.	-16,09%	15,36 mld.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,14%	11,95 mld.
INCYTE CORPORATION	-17,69%	11,6 mld.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,00%	11,51 mld.
SWEDISH ORPHAN BIOVITRUM AB	+5,24%	8,71 mld.